32 results
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
hypoglycaemic agents #Diabetes ... #Diabetic #Medications ... #Pharmacology # ... Dosing #Dosing # ... Impairment #CKD #Table
Insulin and analogues onset of action, peak times and duration.

Follow at www.instagram.com/rxnotes for more!

#pharmacology #table #comparison
#pharmacology #table ... #comparison #dosing ... #insulin #diabetes
Vasopressors Table 
Rough properties by Target Receptor, Heart Rate/Inotropy, Systemic Vascular Resistance, Cardiac Output, Blood Pressure,
Vasopressors Table ... Resistance, Main Uses ... Dobutamine 2-20 mcg ... Vasopressors #Properties #Table ... #Pharmacology #
Insulin Dosing Basics - Initiating Insulin for T2DM and Converting Insulin Products 

Insulin dosing can be
Insulin Dosing Basics ... For type 2 diabetes ... insulin for type 2 diabetes ... run into patient cases ... #Prescribing #Pharmacology
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Diabetes Mellitus ... Medication Guide Classes ... insulin in Type 1 Diabetes ... #Medications #pharmacology ... #comparison #table
Metformin Pharmacology Summary
Mechanisms of Action:
 • Suppresses gluconeogenesis by the liver
 • Increases insulin-mediated glucose utilization
Metformin Pharmacology ... agent • Does not cause ... e.g. diarrhea, nausea ... #Metformin #Pharmacology ... #Summary #DM2 #diabetes
Basophilia - Differential Diagnosis Framework

Basophils < 1% of the total white blood cell count
Basophils function similarly
which are released during ... myeloid leukemia (CML ... (Myxedema) Diabetes ... Chickenpox Other Causes ... Differential #Diagnosis #causes
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
4 Inhibitors - Pharmacology ... Januvia) - Once/day tablet ... not definitively cause ... DPP4 #Inhibitors #Pharmacology ... #Summary #DM2 #diabetes
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... mucoadhesive buccal tablet ... chew, or crush tablet ... suspension 4–6 mL ... infections #HIVAIDS #pharmacology
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
Receptor Agonists - Pharmacology ... Ozempic), or daily tablet ... not definitively cause ... Receptor #Agonists #Pharmacology ... #Summary #DM2 #diabetes